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Antimicrobial resistance in foodborne pathogens and 
commensals is of global concern due to its public health 
consequences. European Food Safety Authority (2008) reports about 
evidence of the link between extensive antimicrobial use in the food-
producing animal sector and the appearance of resistant strains in 
human beings. There are many reports regarding prevalence of 
antimicrobial-resistant bacteria, that have been recovered from 
various foods, including vegetables, confectionary, milk and dairy 
products, but the majority of resistant strains have been isolated from 
traditional retail meats and poultry. 
Constant inadequate usage of antimicrobials in the animal 
producing sector leads to occurrence of “superbugs” – multidrug 
resistant bacteria, including those resistant to clinically important, 
frontline antimicrobials. Infections with resistant pathogenic bacteria 
often result in reduced treatment efficacy, prolonged illness, 
increased morbidity and mortality. This fact emphasizes the public 
health value of continuing efforts to educate animal producers in due 
handling, consumers in proper food handling and preparation 
methods, as well as the importance of sustained surveillance of 
isolates from throughout the food production area to detect emerging 
antimicrobial resistance phenotypes. 
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Dyslipidemia is one of the key risk factors of cardiovascular 
disease (CVD) for patients with type 2 diabetes mellitus (DM). 
Endothelial and vascular dysfunction in large arteries and 
microcirculation are caused by chronic hyperglycemia, 
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hyperlipidemia, and hyperinsulinemia. Previous studies have 
indicated that treatment of dyslipidemia is very important for 
prevention cardiovascular complications.  
The purpose of our study was the determination of particular 
qualities, connected with lipid profile, for patients with DM and 
coexistent arterial hypertension (AH) for improving of treatment and 
prevention cardiovascular complications.   
Participants and methods. We examined 198 patients with 
type 2 DM and AH during our clinical trial. They were treated in 
Sumy City Clinical Hospital № 1 from October 1, 2015 to February 
15, 2016. People from the first (I) group had coexistence of type 2 
DM and AH. The second (II) group includes 49 practically healthy 
people. Such components of lipid profile as general cholesterol (GH), 
triglycerides (TG), high density lipoproteins (HDL), low density 
lipoproteins (LDL) were defined in blood by biochemical method. 
All data were analyzed with the help of statistical methods (Excel 
2013). In addition, we evaluated the Student criteria (t), Pearson ratio 
(r) and the veracity of differences (p) for assessment results. 
Results.  The mean duration of type 2 DM was (9,57±0,73) 
years and of AH - (4,58±0,34) years. The mean levels of GH for 
persons of I and II group were (28,56±2,1) mmol/l, (4,6±0,3) mmol/l,  
t=2,03, p<0,05; TG - (2,49±0,19) mmol/l, (1,7±0,3) mmol/l, t=2,49, 
p<0,05; HDL - (1,15±0,03) mmol/l, (1,47±0,1) mmol/l, t=3,07, 
p<0,01; LDL - (2,82±0,02) mmol/l, (2,61±0,1) mmol/l, t=2,06, 
p<0,05. All data were clinically significant. 
Conclusion. In addition, there are the disorders of lipid profile 
for people with type 2 DM and coexistent AH. In our clinical trial we 
determined the significant increase of atherogenic lipoproteins, 
which leads to cardiovascular complications for patients with type 2 
DM. 
 
 
 
 
 
